Salem Media to Be Acquired by WaterStone in Major Growth Deal
Disappointment Doesn't Come Close to Describing What Just Happened in South Carolina
Scott Jennings Couldn't Let This Insane Take on Redistricting Slide on CNN Last...
The Story of the Reporter Who Attacked Kash Patel Just Took a Wild...
HHS Secretary Marty Makary to Resign Today
AOC Bashes MTG As Progressives Seek Common Ground
Here's Why a Catholic Counselor Is Suing the State of Oregon
Twin Cities Voters Are Learning the Consequences of Minimum Wage Laws
This Is How You Know Hakeem Jeffries Is Losing His 'Maximum Warfare' Battle
Karen Bass and Nithya Raman Bailed on the Next L.A. Mayoral Debate; Spencer...
Marco Rubio to Attend China Summit With Trump, Even Though the Country Banned...
Kash Patel Claps Back in Fiery Senate Hearing As Chris Van Hollen Accuses...
Kuwait Confirms Iranian Security Breach at Strategic Port Project
US Appeals Court Restores President Trump's Second Round of Tariffs
ICE Uncovered a Massive Immigration Fraud Scheme
Tipsheet

Trump Threatens to Impose Pharma Tariffs of Up to 250 Percent

Trump Threatens to Impose Pharma Tariffs of Up to 250 Percent
AP Photo/Mark Schiefelbein

On Tuesday, President Donald Trump threatened to impose tariffs on pharmaceuticals imported into the U.S. that could eventually reach up to 250 percent. 

This would be the highest rate the president has threatened so far. 

Advertisement

Trump made the remarks on CNBC’s "Squawk Box.” He stated that he would start by imposing a “small tariff” on pharmaceuticals but will raise it to 150 percent and 250 percent by a year-and-a-half “maximum.”  

“We want pharmaceuticals made in our country,” Trump told CNBC.

Earlier in the conversation, Trump stated that he believes that pharmaceuticals, among other things, are separate from the sweeping tariffs he imposes on goods coming from other countries.

The pharmaceuticals tariffs are to be expected in the next week or so, the president said. 

According to Reuters, the United States has been conducting a national security review of the pharmaceutical sector. Due to this, the industry has reportedly been preparing for sector-specific tariffs.

Advertisement

Related:

ECONOMY TARIFFS

One drugmaker, AstraZeneca, recently committed $50 billion to expand its American operations by 2030.

“This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients in America and worldwide,” a statement from the company said. “The drug substance facility, planned to be in the Commonwealth of Virginia, would be AstraZeneca’s largest single manufacturing investment in the world.”

Editor's Note: President Trump is leading America into the "Golden Age" as Democrats try desperately to stop it.  

Help us continue to report on President Trump's successes. Join Townhall VIP and use promo code FIGHT to get 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos